Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Günter R.L. Kenis |
Documentos disponibles escritos por este autor (2)
Refinar búsqueda
Anti-inflammatory effects of antidepressants through suppression of the interferon-γ/interleukin-10 production ratio / Marta Kubera en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 2 (Abril)
[artículo]
Título : Anti-inflammatory effects of antidepressants through suppression of the interferon-γ/interleukin-10 production ratio Tipo de documento: texto impreso Autores: Marta Kubera, Autor ; Ai-Hua Lin, Autor ; Günter R.L. Kenis, Autor Fecha de publicación: 2023 Artículo en la página: pp. 199-206 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastorno depresivo, Fluoxetina, Imipramina, Interferón gamma. Resumen: There is some evidence that major depression-in particular, treatment-resistant depression (TRD)-is accompanied by activation of the inflammatory response system and that proinflammatory cytokines may play a role in the etiology of depression. This study was carried out to examine the effects of antidepressive agents, i.e., imipramine, venlafaxine, L-5-hydroxytryptophan, and fluoxetine on the production of interferon-γ (IFN-γ), a proinflammatory cytokine, and interleukin-10 (IL-10), a negative immunoregulatory cytokine. Link: ./index.php?lvl=notice_display&id=31125
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 2 (Abril) . - pp. 199-206[artículo] Anti-inflammatory effects of antidepressants through suppression of the interferon-γ/interleukin-10 production ratio [texto impreso] / Marta Kubera, Autor ; Ai-Hua Lin, Autor ; Günter R.L. Kenis, Autor . - 2023 . - pp. 199-206.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 2 (Abril) . - pp. 199-206
Palabras clave: Antidepresivos, Trastorno depresivo, Fluoxetina, Imipramina, Interferón gamma. Resumen: There is some evidence that major depression-in particular, treatment-resistant depression (TRD)-is accompanied by activation of the inflammatory response system and that proinflammatory cytokines may play a role in the etiology of depression. This study was carried out to examine the effects of antidepressive agents, i.e., imipramine, venlafaxine, L-5-hydroxytryptophan, and fluoxetine on the production of interferon-γ (IFN-γ), a proinflammatory cytokine, and interleukin-10 (IL-10), a negative immunoregulatory cytokine. Link: ./index.php?lvl=notice_display&id=31125 Therapygenetics / Inge J.E. Knuts en European Neuropsychopharmacology, Año 2014 - Vol. 24 - No.8 (Agosto)
[artículo]
Título : Therapygenetics : 5-httlpr genotype predicts the response to exposure therapy for agoraphobia Tipo de documento: texto impreso Autores: Inge J.E. Knuts, Autor ; Gabriel Esquivel, Autor ; Günter R.L. Kenis, Autor Fecha de publicación: 2021 Artículo en la página: pp. 1222-1228 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Terapia de comportamiento, Terapia de exposición, Genética, Trastorno de pánico, Agorafobia, Serotonina Resumen: This study was intended to assess the extent to which the low-expression allele of the serotonin transporter gene promoter predicts better response to exposure-based behavior therapy in patients with panic disorder with agoraphobia (PDA). Link: ./index.php?lvl=notice_display&id=26895
in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.8 (Agosto) . - pp. 1222-1228[artículo] Therapygenetics : 5-httlpr genotype predicts the response to exposure therapy for agoraphobia [texto impreso] / Inge J.E. Knuts, Autor ; Gabriel Esquivel, Autor ; Günter R.L. Kenis, Autor . - 2021 . - pp. 1222-1228.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.8 (Agosto) . - pp. 1222-1228
Palabras clave: Terapia de comportamiento, Terapia de exposición, Genética, Trastorno de pánico, Agorafobia, Serotonina Resumen: This study was intended to assess the extent to which the low-expression allele of the serotonin transporter gene promoter predicts better response to exposure-based behavior therapy in patients with panic disorder with agoraphobia (PDA). Link: ./index.php?lvl=notice_display&id=26895